Lv0
0 积分 2025-03-17 加入
Early stage NSCLC — challenges to implementing ctDNA-based screening and MRD detection
1小时前
待确认
Circulating tumor DNA-minimal residual disease: An up-and-coming nova in resectable non-small-cell lung cancer
1小时前
已完结
Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stages I to IIIA EGFR-Mutant Non–Small Cell Lung Cancer
2小时前
已完结
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients
3小时前
已完结
Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancer
4小时前
已完结
Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancer
5小时前
已完结
Analysis of Circulating Tumor DNA Predicts Outcomes of Short-Course Consolidation Immunotherapy in Unresectable Stage III NSCLC
5小时前
已完结
皖公网安备34019202002308
